R
Ralitza Gueorguieva
Researcher at Yale University
Publications - 242
Citations - 15200
Ralitza Gueorguieva is an academic researcher from Yale University. The author has contributed to research in topics: Randomized controlled trial & Medicine. The author has an hindex of 53, co-authored 210 publications receiving 13013 citations. Previous affiliations of Ralitza Gueorguieva include Emory University & Veterans Health Administration.
Papers
More filters
Journal ArticleDOI
Smoking history and the association between alcohol and e-cigarette use: Authors' reply
Walter Roberts,Terril L. Verplaetse,MacKenzie R. Peltier,MacKenzie R. Peltier,Kelly E. Moore,Ralitza Gueorguieva,Sherry A. McKee +6 more
Journal ArticleDOI
Evaluating computational models of language disturbance in schizophrenia
Uli Grasemann,Ralph E. Hoffman,Ralitza Gueorguieva,Donald M. Quinlan,Douglas Lane,Risto Miikkulainen +5 more
TL;DR: This research highlights the need to understand more fully the role that language plays in the development of dementia and its role in the care and treatment of patients with learning disabilities.
Journal ArticleDOI
Correction to: Dose-related effects of ketamine for antidepressant-resistant symptoms of posttraumatic stress disorder in veterans and active duty military: a double-blind, randomized, placebo-controlled multi-center clinical trial
Chadi G. Abdallah,John D. Roache,Ralitza Gueorguieva,Lynnette A. Averill,Stacey Young-McCaughan,Paulo R. Shiroma,Prerana Purohit,Antoinette Brundige,William L. Murff,Kyung-Heup Ahn,Mohamed Sherif,Eric Baltutis,Mohini Ranganathan,Deepak Cyril D'Souza,Brenda Martini,Steven M. Southwick,Ismene L. Petrakis,Rebecca R. Burson,Kevin B. Guthmiller,Argelio López‐Roca,Karl Alan Lautenschlager,John P. McCallin,Matthew C. Hoch,A. Timchenko,Sérgio Luz e Souza,Charles E. Bryant,Jim Mintz,Brett T. Litz,Douglas E. Williamson,Terence M. Keane,Alan L. Peterson,John H. Krystal +31 more
Journal ArticleDOI
Naltrexone plus bupropion combination medication maintenance treatment for binge-eating disorder following successful acute treatments: randomized double-blind placebo-controlled trial.
TL;DR: In this paper , the authors tested the efficacy of naltrexone/bupropion maintenance treatment among responders to acute treatments for BED and found that maintenance treatment was associated with good maintenance of binge eating remission, low binge eating frequency, and significant additional weight loss.
Journal ArticleDOI
Randomized controlled trial of the glycine transporter 1 inhibitor PF-03463275 to enhance cognitive training and neuroplasticity in schizophrenia
Toral Surti,Mohini Ranganathan,Jason K. Johannesen,Ralitza Gueorguieva,Emma Deaso,Joshua Kenney,John H. Krystal,Deepak Cyril D'Souza +7 more
TL;DR: In this article , the authors examined whether co-administration of a GLYT1 inhibitor and computerized CT would have synergistic effects on cognitive impairments associated with schizophrenia (CIAS).